Abstract
Background
It has been demonstrated that the prognosis of liver transplantation (LT) is significantly influenced by pretransplant factors, such as diabetes mellitus (DM). However, inconsistent observations are obtained.
Methods
We comprehensively searched PubMed, Embase and Web of Science to identify eligible cohort studies to evaluate the impact of preexisting DM on LT prognosis. Overall mortality and graft loss, as the most frequently observed parameters, were used to evaluate the outcomes of LT. Hazard ratios (HRs) with their 95% confidence intervals (CIs) were pooled to assess the effect of DM.
Results
15,768 diabetic LT recipients and 60,176 non-diabetic LT recipients from 13 populations were included in this meta-analysis. Preexisting DM increased the risk for overall death of LT by 40% (95% CI 1.22–1.61), compared with DM-free patients. In addition, the risk for graft loss was also elevated by pretransplant DM (HR 1.28, 95% CI 1.07–1.54). Both analyses showed high heterogeneities (I 2 = 85.2 and 93.2%, respectively) and their sources were not identified by meta-regression analyses. In terms of the additive effect of hepatitis C virus (HCV) infection on poor outcomes of diabetic LT recipients, stratified meta-analyses were conducted. It was demonstrated that HCV infection increased the risk for mortality by 73% (95% CI 1.64–1.83), relatively higher than non-HCV recipients (HR 1.32, 95% CI 1.25–1.39) and general population (HR 1.40, 95% CI 1.22–1.61).
Conclusion
Preexisting DM predicts worse patient and graft survivals of LT. Concomitant HCV infection would further deteriorate this unfavorable impact. Given the high heterogeneities and the insufficient evidences, more studies are still warranted to support these observations.
Similar content being viewed by others
References
Yang JD et al (2016) Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States. Clin Gastroenterol Hepatol 15:767–775
Agopian VG et al (2013) The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg 258(3):409–421
Adams LA et al (2016) Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant. J Gastroenterol Hepatol 31(5):1016–1024
Barritt AS et al (2011) The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. J Clin Gastroenterol 45(4):372–378
Martin EF et al (2012) Recipient survival and graft survival are not diminished by simultaneous liver–kidney transplantation: an analysis of the united network for organ sharing database. Liver Transpl 18(8):914–929
Narayanan Menon KV et al (2004) MELD and other factors associated with survival after liver transplantation. Am J Transpl 4(5):819–825
Siegel AB et al (2012) Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation 94(5):539–543
Tovikkai C et al (2015) Time-varying impact of comorbidities on mortality after liver transplantation: a national cohort study using linked clinical and administrative data. BMJ Open 5(5):e006971
Perumpail RB et al (2015) HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States. Clin Transpl 29(10):920–926
Tsai MS et al (2015) Pre-existing diabetes and risks of morbidity and mortality after liver transplantation: a nationwide database study in an Asian population. Eur J Intern Med 26(6):433–438
Hoehn RS et al (2015) Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study. Liver Int 35(7):1902–1909
Skaro AI et al (2016) The impact of coronary artery disease on outcomes after liver transplantation. J Cardiovasc Med (Hagerstown) 17(12):875–885
Watt KD et al (2010) Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl 16(8):990–998
Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Patel HK et al (2010) Survival after liver transplantation in patients who develop renal insufficiency. Transpl Proc 42(10):4167–4170
Samuelson AL et al (2010) Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score. Dig Dis Sci 55(7):2089–2094
Ramos-Prol A et al (2015) Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant. Diabetes Res Clin Pract 110(2):123–128
Kuo HT et al (2010) Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 89(9):1134–1140
Alvarez-Sotomayor D et al (2016) Controlling diabetes after liver transplantation: room for improvement. Transplantation 100(10):e66–e73
Sprinzl MF et al (2013) Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. Transpl Int 26(1):67–74
Katsura E et al (2016) Elevated fasting plasma glucose before liver transplantation is associated with lower post-transplant survival. Med Sci Monit 22:4707–4715
Lontchi-Yimagou E et al (2013) Diabetes mellitus and inflammation. Curr Diab Rep 13(3):435–444
Yue S et al (2015) Hyperglycemia and liver ischemia reperfusion injury: a role for the advanced glycation endproduct and its receptor pathway. Am J Transplant 15(11):2877–2887
Dare AJ et al (2014) Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation. Liver Transpl 20(3):281–290
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
None.
Rights and permissions
About this article
Cite this article
Li, P., Fan, H. & He, Q. Pretransplant diabetes mellitus predicts worse outcomes of liver transplantation: evidence from meta-analysis. J Endocrinol Invest 41, 211–221 (2018). https://doi.org/10.1007/s40618-017-0721-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-017-0721-z